Quantcast

Latest TULSA Stories

2013-09-17 23:32:11

Profound Medical is pleased to announce that the FDA has granted it IDE approval to conduct a clinical study of its device for the treatment of localized prostate cancer. Toronto, Ontario (PRWEB) September 17, 2013 Profound Medical Inc. today announced that the US Food and Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval to the company to conduct a clinical study of its device for the treatment of localized prostate cancer. The company is now...


Word of the Day
negawatt
  • A unit of saved energy.
Coined by Amory Lovins, chairman of the Rocky Mountain Institute as a contraction of negative watt on the model of similar compounds like megawatt.